← All Sponsors
SPONSOR

University of Southern California

Total Trials
14
Recruiting
14
Phases
Phase 4, Phase 2, Phase 1

University of Southern California is a clinical research sponsor with 14 registered studies on ClinicalTrials.gov, of which 14 are actively recruiting participants. Research covers conditions including Infertility, Female, No Condition, Study Mental State in Healthy Populations and Drug-resistant Epilepsy Patients With Existing iEEG, Acute Lymphoblastic Leukemia.

The trial portfolio spans Phase 4, Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University of Southern California

How many clinical trials has University of Southern California sponsored?
ClinicalMetric currently tracks 14 clinical trials sponsored by University of Southern California, of which 14 are actively recruiting participants. These trials cover conditions including Infertility, Female, No Condition, Study Mental State in Healthy Populations and Drug-resistant Epilepsy Patients With Existing iEEG. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Southern California research focus on?
University of Southern California clinical trials span Infertility, Female, No Condition, Study Mental State in Healthy Populations and Drug-resistant Epilepsy Patients With Existing iEEG, Acute Lymphoblastic Leukemia, Lung Non-Small Cell Carcinoma, and additional conditions. The research pipeline includes Phase 4, Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Southern California clinical trial?
To participate in a University of Southern California trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Southern California trials with current recruitment status updated daily.

Clinical Trials by University of Southern California

NCT06701071 Phase 4
Recruiting

Evaluation of a Long Versus Short Clomid Protocol for Controlled Ovarian Stimulation

Infertility, Female
NCT07110688
Recruiting

Novel Multimodal Neural, Physiological, and Behavioral Sensing and Machine Learning for Mental States

No Condition
NCT03568266
Recruiting

Pharmacogenomics of Asparaginase Induced Hepatotoxicity

Acute Lymphoblastic Leukemia
NCT07186699
Recruiting

Qualitative Study on Detection & Tx of NSCLC in Pts w/ a History of Alcohol or SUD

Lung Non-Small Cell Carcinoma
NCT02434393
Recruiting

Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project

Major Depression
NCT02250352
Recruiting

Core Biopsies for Establishing a Breast Tumor Tissue Repository

Breast Cancer
NCT07279571
Recruiting

GYN-AIDE: Gynecologic Oncology Navigation Through AI-Driven Education

Gynecologic Disease
NCT06774300
Recruiting

Evaluating Telehealth Delivery of Brief Alcohol Screening and Intervention for College Students

Alcohol Consumption
NCT04873102 Phase 2
Recruiting

Danazol for Treatment of Cytopenias in Patients With Cirrhosis

Cirrhosis, Liver
NCT07602699 Phase 2
Recruiting

Multi-Site Trial of Tirzepatide for Smoking Cessation

Smoking Cessation
NCT05867381
Recruiting

Using Indoor Air Filtration to Slow Atherothrombosis Progression in Adults With Ischemic Heart Disease History

Air Pollution
NCT06747637
Recruiting

Demonstrating the Efficacy of a Spanish-Language Program for Latino Dementia Caregivers

Caregiver Burden of People With Dementia
NCT06410157
Recruiting

Cardiac-Control Affecting Learning Through Mindfulness (CALM)

Age-related Cognitive Decline
NCT05989828 Phase 1
Recruiting

A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer

Triple Negative Breast Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology